| Catalog | name | Description | price | 
|---|---|---|---|
| R-R-2355 | Homoharringtonine CAS No.26833-87-4 | Homoharringtonine (Omacetaxine mepesuccinate;HHT)/CAS No.26833-87-4 is a cytotoxic alkaloid with antitumor properties which acts by inhibiting translation elongation. | price> | 
| R-R-2356 | STAT6-IN-2 CAS No.1355594-85-2 | STAT6-IN-2 (Comp R-84)/CAS No.1355594-85-2 is an inhibitor of STAT6. STAT6-IN-2 inhibits the secretion of chemokine eliciting eosinophil infiltration eotaxin-3. STAT6-IN-2 can be used for immune disease research. | price> | 
| R-R-2357 | STAT6-IN-3 CAS No.371919-80-1 | STAT6-IN-3 (Compound 18a)/CAS No.371919-80-1 is a STAT6 inhibitor (IC50= 44 nM). STAT6-IN-3 targets the Src Homology 2 (SH2) domain of STAT6. STAT6-IN-3 can be used for research of inflammation such as asthma. | price> | 
| R-R-2358 | AS1517499 CAS No.919486-40-1 | AS1517499/CAS No.919486-40-1 is a potent and brain-permeable STAT6 phosphorylation inhibitor with an IC50 of 21 nM. | price> | 
| R-C-659 | XL019 CAS:945755-56-6 | XL019 is a potent,orally active,and selective JAK2 inhibitor,with IC50s of 2.2,134.3,and 214.2 nM for JAK2,JAK1 and JAK3,respectively.XL019 shows 50-fold or greater selectivity for JAK2,versus a panel of over 100 serine/threonine and tyrosine kinases,including other members of the JAK family.XL019 potently inhibits STAT3 and STAT5 phosphorylation in cells harboring either JAK2V617F or wild-type JAK2. | price> | 
| R-R-2359 | Cryptotanshinone CAS No.35825-57-1 | Cryptotanshinone/CAS No.35825-57-1 is a natural compound extracted from the root of Salvia miltiorrhiza Bunge that shows antitumor activities. Cryptotanshinone inhibits STAT3 with an IC50 of 4.6 μM. | price> | 
| R-R-2360 | STAT5-IN-1 CAS No.285986-31-4 | STAT5-IN-1/CAS No.285986-31-4 is a STAT5 inhibitor with an IC50 of 47 μM for STAT5β isoform. | price> | 
| R-R-2361 | AC-4-130 CAS No.1834571-82-2 | AC-4-130/CAS No.1834571-82-2 is a potent STAT5 SH2 domain inhibitor. AC-4-130 directly binds to STAT5 and disrupts STAT5 activation, dimerization, nuclear translocation, and STAT5-dependent gene transcription. AC-4-130 induces cell cycle arrest and apoptosis in FLT3-ITD-driven leukemic cells. AC-4-130 has anti-cancer activity and can efficiently block pathological levels of STAT5 activity in acute myeloid leukemia (AML). | price> | 
| R-R-2362 | SD-36 CAS No.2429877-44-9 | SD-36/CAS No.2429877-44-9 is a potent and efficacious STAT3 PROTAC degrader (Kd=~50 nM), and demonstrates high selectivity over other STAT members. SD-36 also effectively degrades mutated STAT3 proteins in cells and suppresses the transcriptional activity of STAT3 (IC50=10 nM). SD-36 exerts robust anti-tumor activity, and achieves complete and long-lasting tumor regression in mouse tumor models. SD-36 is composed of the STAT3 inhibitor SI-109, a linker, and an analog of Cereblon ligand Lenalidomide for E3 ubiquitin ligase. SD-36 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | price> | 
| R-R-2363 | 2-NP CAS No.65182-56-1 | 2-NP/CAS No.65182-56-1 is a selective enhancer of STAT1 transcription. 2-NP can enhance the ability of IFN-γ to inhibit the proliferation of human breast cancer and fibrosarcoma cells. | price> | 

 Items-$0.00
Items-$0.00

 Email:
Email: Tel.:
Tel.: RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                 Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                 Tel:  02988811435
                    Tel:  02988811435
                 Fax: (86-29)8881-1435
                    Fax: (86-29)8881-1435
                 Email: sales@ruixibiotech.com
                    Email: sales@ruixibiotech.com
                 Web: http://www.ruixibiotech.com
                    Web: http://www.ruixibiotech.com    
					
							
                

